David Andrew Talan, MD, FACEP, FIDSA
Professor of Medicine, UCLA School of Medicine
Chair, Department of Emergency Medicine, Olive View-UCLA Medical Center
Faculty, Division of Infectious Diseaes, Olive View-UCLA Medical Center

Dept of Emergency Medicine
Olive View-UCLA Medical Center
14445 Olive View Drive - North Annex
Sylmar, CA 91342
Phone: (818) 364-3107
Fax: (818) 364-3268
dtalan@ucla.edu

Dr. Talan received his medical degree from the University of Illinois Medical College in Chicago. He completed his residencies (Internal and Emergency Medicine) and Infectious Diseases fellowship at the University of California Los Angeles (UCLA) and its associated medical centers. He is board certified in Internal Medicine, Emergency Medicine, and Infectious Diseases.

Currently, Dr. Talan is Chairman of the Department of Emergency Medicine and faculty in the Division of Infectious Diseases at Olive View-UCLA Medical Center, and Professor of Medicine in Residence at UCLA School of Medicine. He is a Fellow of the American College of Emergency Physicians and the Infectious Diseases Society of America, and a member of the Society for Academic Emergency Medicine and the American Society for Microbiology.

Dr. Talan serves on the editorial boards of the Annals of Emergency Medicine, Emergency Medicine News, and Pediatric Emergency Care and is a reviewer for Clinical Infectious Diseases, JAMA, and The Medical Letter. Dr. Talan has written and researched extensively on acute infectious diseases, including animal and human bites, rabies, tetanus, pyelonephritis, meningitis, sepsis, and MRSA skin and soft tissue infections. He has recent publications in the New England Journal of Medicine and JAMA. His current research focuses on emergency department-based surveillance for and epidemiological research of emerging infections. He is principal investigator of a CDC-supported emergency department-based national sentinel network for research on emerging infectious diseases in the United States called EMERGEncy ID NET. He is also principal investigator of an NIH contract to study off patent antibiotics to treat skin and soft tissue infections caused by community-associated MRSA.

Selected Publications:

  1. Talan DA, Hoffman JR, Yoshikawa TT, Overturf GD. A review of the role of empiric parenteral antibiotics prior to lumbar puncture in suspected bacterial meningitis: the state-of-the-art. Rev Infect Dis. 1988;10:365-376.
  2. Talan DA, Guterman JJ, Overturf GD, Singer CM, Hoffman JR, Lambert B. Analysis of the emergency department management of bacterial meningitis. Ann Emerg Med. 1989;18:856-862.
  3. Tan TS, Wishnow RM, Talan DA and the Piperacillin/Tazobactam Skin and Skin Structure Study Group. Treatment of hospitalized patients with skin and skin structure infections: A double blind, randomized, multicenter study of piperacillin/tazobactam versus ticarcillin/clavulanate. Antimicrob Agents Chemother 1993;37:1580-1586.
  4. Moran GJ, Fuchs MA, Jarvis WR, Talan DA. Tuberculosis infection-control practices in United States emergency departments. Ann Emerg Med. 1995;26:283-289.
  5. Talan DA. Infectious disease issues in the emergency department. (State-of-the-Art Clinical Article) Clin Infect Dis. 1996;23:1-14.
  6. Kyriacou DN, Spira AM, Talan DA, Mabey DCW. Emergency department presentation and misdiagnosis of imported falciparum malaria. Ann Emerg Med. 1996;27:696-699.
  7. Talan DA, Moran GJ, Mower WR, Newdow M, Ong S, Slutsker L, Jarvis WR, Conn LA, Pinner RW, for the EMERGEncy ID NET Study Group. EMERGEncy ID NET: An emergency department-based emerging infections sentinel network. Clin Infect Dis. 1999;28:401-2.
  8. Talan DA, Citron DM, Abrahamian FM, Moran GJ, Goldstein EJC, for the Emergency Medicine Animal Bite Infection Study Group. Bacteriologic analysis of dog and cat bite wound infections. N Engl J Med. 1999;340:85-92.
  9. Talan DA, Stamm WE, Hooton TM, Moran GJ, Burke T, Iravani A, Reuning-Scherer J, Church DA. Comparison of ciprofloxacin (7 days) and trimethoprim/sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA. 2000;283:1583-90.
  10. Talan DA, Summanen PH, Finegold SM. Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft tissue abscesses in patients with and without histories of injection drug abuse. Clin Infect Dis. 2000;31:464-71.
  11. Moran GJ, Talan, DA, Newdow M, Ong S, Nakase J, Pinner RW, Childs JE, for the EMERGEncy ID NET Study Group. Appropriateness of emergency department rabies post-exposure prophylaxis for animal exposures. JAMA. 2000;284:1001-7.
  12. Talan DA, Moran GJ, Newdow M, Ong S, Mower WR, Nakase JY, Pinner RW, Slutsker L, for the EMERGEncy ID NET Study Group. Etiology of bloody diarrhea among patients presenting to United States emergency departments: prevalence of E. coli O157:H7 and other enteropathogens. Clin Infect Dis. 2001;32:573-80.
  13. Graham DR, Talan DA, Nichols RL, Lucasti C, Corrado M, Morgan N, Fowler CL. The efficacy and safety of once-daily levofloxacvin at higher dose for complicated skin and skin-structure infections: a randomized open-label trial comparing levofloxacin to ticarcillin/clavulante alone or followed by amoxicillin/clavulanate. Clin Infect Dis. 2002;35:381-9.
  14. Ong S, Talan DA, Moran GJ, Mower W, Newdow M, Tsang VCW, Pinner RW. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis. 2002;8:608-13.5.
  15. Talan DA, Abrahamian FM, Moran GJ, Citron DM, Tan JO, Goldstein EJC, for the Emergency Medicine Human Bite Infection Study Group. Clinical presentation and bacteriologic analysis of infected human bites presenting to emergency departments. Clin Infect Dis. 2003;37:1481-9.
  16. Karras DJ,  Ong S,  Moran GJ, Nakase J,  Kuehnert MJ, Jarvis WR, Talan DA  for the EMERGEncy ID NET Study Group. Antibiotic use for emergency department patients with acute diarrhea: prescribing practices, patient expectations, and patient satisfaction. Ann Emerg Med. 2003;42:835-42.
  17. Talan DA, Abrahamian FM, Moran GJ, Mower WR, Alagappan K, Tiffany BR, Pollack Jr CV, Steele MT, Dunbar LM, Bajani MD, Weyant RS, Ostroff SM. Tetanus immunity and physician compliance with tetanus prophylaxis practices among emergency department patients presenting with wounds. Ann Emerg Med. 2004;43:305-14.
  18. Moran GJ, Amii RN, Abrahamian FM, Talan DA. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis. 2005;11:928-930.
  19. Nguyen HB, Rivers EP, Abrahamian FM, Moran GJ, Abraham E, Osborne T, Trezciak S, Huang D, Stevens D, Talan DA. Concensus guidelines for the treatment of severe sepsis and septic shock in the emergency department. Ann Emerg Med. 2006;48:28-54.
  20. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA for The EMERGEncy ID NET Study Group. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666-74. 
  21. Ong S, Nakase J, Moran GJ, Karras DJ, Kuehnert MJ, Talan DA, The EMERGEncy ID Net Study Group. Antibiotic Use for Emergency Department Patients With Upper Respiratory Infections:  Prescribing Practices, Patient Expectations, and Patient Satisfaction. Ann Emerg Med 2007;50(3):213-20.
  22. Talan DA. MRSA: deadly super bug or just another staph?  Ann Emerg Med 2008;51(3):299-302.
  23. Talan DA, Moran GJ, Abrahamian FM. Severe sepsis and septic shock.  Infect Dis Clin North Am 2008;22(1):1-31.
  24. Fitch MT, Abrahamian FM, Moran GJ, Talan DA.  Emergency department management of meningitis and encephalitis.  Infect Dis Clin North Am 2008;22(1):33-52.
  25. Moran GJ, Talan DA, Abrahamian FM. Diagnosis and management of pneumonia in the emergency department.  Infect Dis Clin North Am 2008;22(1):53-72.
  26. Abrahamian FM, Moran GJ, Talan DA. Urinary tract infections in the emergency department.  Infect Dis Clin North Am 2008;22(1):73-87.
  27. Abrahamian FM, Talan DA, Moran GJ. Management of skin and soft tissue infections in the emergency department.  Infect Dis Clin North Am 2008;22(1):89-116
  28. Moran GJ, Talan DA, Abrahamian FM. Antimicrobial prophylaxis for wounds and procedures in the emergency department.  Infect Dis Clin North Am 2008;22(1): 117-143.
  29. Moran GJ, Talan DA, Abrahamian FM. Biological terrorism.  Infect Dis Clin North Am 2008;22(1): 145-187.
  30. Talan DA, Krishnadasan A, Abrahamian FM, Stamm WE, Moran GJ for The EMERGEncy ID NET Study Group. Prevalence and risk factor analysis of trimethoprim/sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis. 2008 (in press).
  31. Moran GJ, Barrett TW, Mower WR, Krishnadasan A, Abrahamian F, Ong S, Nakase JY, Pinner RW, Kuehnert MJ, Jarvis WR, Talan DA for the EMERGEncy ID NET Study Group. Decision instrument for the isolation of pneumonia patients with suspected pulmonary tuberculosis admitted through U.S. emergency departments. Ann Emerg Med. 2008 (in press).

 

2008